Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Korosho Draft Budget Increases 3.1% to \20.8 Trillion
January 3, 2005
- Looking at the Year Ahead
January 3, 2005
- NEW PRODUCTS
January 3, 2005
- New year's Commentary
January 3, 2005
- Challenges Ahead for Everyone
January 3, 2005
- Blopress Passes Mevalotin as Top-selling Drug in 1st Half
January 3, 2005
- AstraZeneca Aims at Gaining 20% of Statin Market by Crestor: Dr Kato
January 3, 2005
- Tanabe Completes Enrollment of 1st 5,000 Remicade Users
January 3, 2005
- Sales of Kyowa Hakko's Allelock Expected to Rise 35% in 2nd Half
January 3, 2005
- Schering-Plough to Use New Formulation, New Evidence to Boost Sales of Claritin
January 3, 2005
- Eisai Recieves A Positive Opinion for Zonegran Approval from EMEA
January 3, 2005
- BUSINESS NEWS IN BRIEF
January 3, 2005
- DIAGNOSTIC NEWS IN BRIEF
January 3, 2005
- Reform Council, Korosho Finally Agree on "Mixed Medical Care"
January 3, 2005
- 2004 Spot Test Market Totals \94.4 Bil. in 2003: Fuji-keizai
December 27, 2004
- MEDICAL DEVICE NEWS IN BRIEF
December 27, 2004
- Astellas Pharma to Explore Any Possibility to Become a Global Mega Pharma
December 27, 2004
- Norvasc Ranked at Top in 3rd Qtr: IMS Data
December 27, 2004
- Sanofi-Synthelabo, Aventis Pharma to Consolidate Their Businesses in January 2005
December 27, 2004
- Kaken to Make Trafermin Blockbuster by Add. Indication, Formulation
December 27, 2004
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…